Healthcare Portal Investment Opportunities in London

1. Innovative Products and Services: The company offers a digital therapeutics IoT platform that provides personalized and clinically validated treatment, monitoring, and diagnostics for sleep disorders and neurological diseases. The solution integrates mobile software with an EEG headband and wearable rings. 2. Global Presence: With subsidiaries in Brazil, Abu Dhabi, and the USA, the company has positioned itself for international growth and market expansion. 3. Outsourced Manufacturing: The company currently outsources the manufacturing of its products, allowing for flexibility and cost-efficiency in production. 4. Client Base: With over 40,000 accumulated users and diverse clients including telecom, retail pharmacies, sleep clinics, clinicians, and corporates, the company has established a strong and diverse client base. 5. Business Model: The company's business model focuses on B2B and B2B2C partnerships, offering the potential for scalable and sustainable revenue streams. 6. Regulatory Approvals: The company's proprietary solution is approved by Brazilian Anvisa and Abu Dhabi regulatory authorities, with FDA approval in process.

1. Innovative Products and Services: The company offers a digital therapeutics IoT platform that provides personalized and clinically validated treatment, monitoring, and diagnostics for sleep disorders and neurological diseases. The solution integrates mobile software with an EEG headband and wearable rings. 2. Global Presence: With subsidiaries in Brazil, Abu Dhabi, and the USA, the company has positioned itself for international growth and market expansion. 3. Outsourced Manufacturing: The company currently outsources the manufacturing of its products, allowing for flexibility and cost-efficiency in production. 4. Client Base: With over 40,000 accumulated users and diverse clients including telecom, retail pharmacies, sleep clinics, clinicians, and corporates, the company has established a strong and diverse client base. 5. Business Model: The company's business model focuses on B2B and B2B2C partnerships, offering the potential for scalable and sustainable revenue streams. 6. Regulatory Approvals: The company's proprietary solution is approved by Brazilian Anvisa and Abu Dhabi regulatory authorities, with FDA approval in process.